UDG.L - UDG Healthcare plc

LSE - LSE Delayed price. Currency in GBp
907.00
+7.00 (+0.78%)
At close: 4:35PM BST
Stock chart is not supported by your current browser
Previous close900.00
Open899.50
Bid850.00 x 1900
Ask0.00 x 86500
Day's range899.50 - 926.50
52-week range739.50 - 963.00
Volume1,240,699
Avg. volume1,139,437
Market cap2.255B
Beta0.41
PE ratio (TTM)31.49
EPS (TTM)28.80
Earnings dateN/A
Forward dividend & yield0.14 (1.49%)
Ex-dividend date2018-01-11
1y target est12.14
  • Reuters - UK Focus3 days ago

    BUZZ-UDG Healthcare: Sharp's impact

    ** Shares of healthcare services provider down 6.3 pct and set for worst day since November 2016 ** Co posts a 17 pct rise in H1 net revenue to $568.7 mln, reiterates guidance for FY2018 constant currency ...

  • Reuters3 days ago

    UDG Healthcare disappoints on weaker Sharp business

    The company, which provides outsourced sales and marketing, drug distribution and packaging services to healthcare companies, said revenue at Sharp fell 4.4 percent to $118.6 million (88.4 million pounds) in the six months ended March 31. Sharp, which specialises in contract packaging, also saw a 1.6 percent decline in operating profit, hurt by weaker demand for bottling at the division's U.S. business. The company said Sharp is expected to deliver double-digit underlying operating profit growth in the second half of this year, but that will still only leave full year growth in the mid-single digits compared to its earlier guidance of low double digit growth.

  • Reuters - UK Focus3 days ago

    UDG Healthcare disappoints on weaker Sharp business

    Britain's UDG Healthcare (LSE: UDG.L - news) posted a weaker-than-expected first-half performance at its second-largest business, Sharp (Swiss: SHA.SW - news) , on Tuesday and lowered its outlook for the division, sending its shares down more than 6 percent. The company, which provides outsourced sales and marketing, drug distribution and packaging services to healthcare companies, said revenue at Sharp fell 4.4 percent to $118.6 million in the six months ended March 31. Sharp, which specialises in contract packaging, also saw a 1.6 percent decline in operating profit, hurt by weaker demand for bottling at the division's U.S. business.

  • Reuters - UK Focus8 days ago

    BUZZ-Top of the Street: BTG, Integrated oil and refining, Solvay, UDG Healthcare

    A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** BTG: Deutsche Bank says that guidance and performance for key unit Interventional Medicine were softer than its ...

  • 2 FTSE 250 stocks I’d buy and hold for the next 20 years
    Fool.co.uk26 days ago

    2 FTSE 250 stocks I’d buy and hold for the next 20 years

    These two FTSE 250 (INDEXFTSE: MCX) shares could make you a fortune.

  • Reuters4 months ago

    Britain's UDG Healthcare expects 18-21 percent growth in full-year profit

    The company, which provides outsourced sales and marketing, drug distribution and packaging services to healthcare companies, said pre-tax profit in the first quarter of the year was well ahead of last year, helped by recent acquisitions. UDG reported adjusted earnings per share of 37.1 cents, on a constant currency basis, for the year ended Sept. 30, 2017. UDG said it would gain from a reduction in the headline US federal corporate tax rate to 21 percent from 35 percent, adding that its tax rate for 2018 is expected to be 4 percent lower than the 19 percent it had previously expected.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes